Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CYTALUX safely and effectively. See full prescribing information for CYTALUX. CYTALUX® (pafolacianine) injection, for intravenous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
CYTALUX is indicated as an adjunct for intraoperative identification of: Malignant lesions in adult patients with ovarian cancer. Malignant and non-malignant pulmonary lesions in adult patients with known or suspected cancer in the lung.
- generic_name
- pafolacianine injection
- product_names
- Pafolacianine injection
- ndc
- 81052-138, 81052-138-01, 81052-138-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en